IDH1 AND IDH2 GENE MUTATIONS IDENTIFY NOVEL MOLECULAR SUBSETS WITHIN DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML): A CANCER AND LEUKEMIA GROUP B (CALGB) STUDY

被引:0
|
作者
Marcucci, G. [1 ]
Maharry, K. [1 ]
Wu, Y. Z. [1 ]
Radmacher, M. [1 ]
Mrozek, K. [1 ]
Margeson, D. [1 ]
Holland, K. [1 ]
Whitman, S. [1 ]
Becker, H. [1 ]
Schwind, S. [1 ]
Metzeler, K. [1 ]
Powell, B. [2 ]
Carter, T. [3 ]
Kolitz, J. [4 ]
Wetzler, M. [5 ]
Baer, M. [6 ]
Carroll, A. [7 ]
Caligiuri, M. [1 ]
Larson, R. [8 ]
Bloomfield, C. [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
[3] Univ Iowa, Iowa City, IA USA
[4] N Shore Univ Hosp, Manhasset, NY USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Univ Maryland, Baltimore, MD 21201 USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Chicago, Chicago, IL 60637 USA
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1107
引用
收藏
页码:456 / 456
页数:1
相关论文
共 50 条
  • [1] IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
    Marcucci, Guido
    Maharry, Kati
    Wu, Yue-Zhong
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Margeson, Dean
    Holland, Kelsi B.
    Whitman, Susan P.
    Becker, Heiko
    Schwind, Sebastian
    Metzeler, Klaus H.
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Wetzler, Meir
    Carroll, Andrew J.
    Baer, Maria R.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2348 - 2355
  • [2] Implication of IDH1 and IDH2 gene mutations in acute myeloid leukemia
    Llopis, Laura
    Nibourel, Olivier
    Boissel, Nicolas
    Huchette, Pascal
    Renneville, Aline
    Abdelhamid, Emma
    Dombret, Herve
    Preudhomme, Claude
    HEMATOLOGIE, 2011, 17 (02): : 132 - 144
  • [3] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Ragon, Brittany Knick
    DiNardo, Courtney D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 537 - 546
  • [4] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Brittany Knick Ragon
    Courtney D. DiNardo
    Current Hematologic Malignancy Reports, 2017, 12 : 537 - 546
  • [5] Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia
    Wang, Jinghan
    Ma, Zhixin
    Wang, Qinrong
    Yu, Mengxia
    Yin, Xiufeng
    Li, Xia
    Suo, Shanshan
    Shen, Dan
    Wang, Yungui
    Huang, Xin
    Pan, Hanzhang
    Wang, Huanping
    Chen, Zhimei
    Huang, Jiansong
    Mao, Liping
    Yu, Wenjuan
    Wei, Juying
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Tong, Hongyan
    Chen, Suning
    Marcucci, Guido
    Chen, Saijuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [6] Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients
    Aref, Salah
    Areida, El Sayed Kamel
    Aaal, Mohamed Fathy Abdel
    Adam, Ola Mohamed
    El-Ghonemy, Mohamed Sabry
    El-Baiomy, Mohamed Ali
    Abou Zeid, Tarek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 550 - 555
  • [7] IDH1 and IDH2 Mutations In Pediatric Acute Myeloid Leukemia.
    Andersson, Anna
    Miller, David
    Lynch, John
    Lemoff, Andrew
    Cai, Zhongling
    Pounds, Stanley
    Radtke, Ina
    Bing, Yan
    John, Schuetz
    Jeffrey, Rubnitz
    Ribeiro, Raul
    Raimondi, Susana C.
    Zhang, Jinghui
    Shurtleff, Sheila
    Schulman, Brenda
    Downing, James
    BLOOD, 2010, 116 (21) : 712 - 712
  • [8] Aberrant Gene Expression of BAALC and ERG in Older [≥60 Years (y)] De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) Study
    Schwind, Sebastian
    Marcucci, Guido
    Maharry, Kati
    Mrozek, Krzysztof
    Radmacher, Michael D.
    Holland, Kelsi B.
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Baer, Maria R.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2009, 114 (22) : 93 - 94
  • [9] Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia
    Thol, Felicitas
    Damm, Frederik
    Wagner, Katharina
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Hoelzer, Dieter
    Luebbert, Michael
    Heit, Wolfgang
    Kanz, Lothar
    Schlimok, Guenter
    Raghavachar, Aruna
    Fiedler, Walter
    Kirchner, Hartmut
    Heil, Gerhard
    Heuser, Michael
    Krauter, Juergen
    Ganser, Arnold
    BLOOD, 2010, 116 (04) : 614 - 616
  • [10] MicroRNA (miR) expression signatures in molecular subsets of cytogenetically normal (CN) acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) study
    Radmacher, M. D.
    Marcucci, G.
    Paschka, P.
    Vukosavljevic, T.
    Whitman, S. P.
    Ruppert, A. S.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)